GIA
BIVV

Gateway Investment Advisers’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Gateway Investment Advisers’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-131,579
Closed -$7.09M – 669
2017
Q4 		$7.09M Buy
131,579
+37,667
+40% +$2.06M 0.06% 240
2017
Q3 		$5.36M Sell
93,912
-29,066
-24% -$1.7M 0.05% 272
2017
Q2 		$7.4M Buy
122,978
+54,451
+79% +$3.1M 0.07% 221
2017
Q1 		$3.73M Buy
+68,527
New +$3.38M 0.03% 302

Other funds holding BIVV

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ACS
Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Gateway Investment Advisers's BIVV Position: Q1 2018 in Review

Gateway Investment Advisers sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 131,579 shares — an estimated $7.09M sold.

Gateway Investment Advisers first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $7.4M in Q2 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

  • Gateway Investment Advisers reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • Gateway Investment Advisers sold 131,579 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $7.09M.
  • Gateway Investment Advisers first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
  • Gateway Investment Advisers's Bioverativ Inc. Common Stock position peaked at $7.4M in Q2 2017.
  • 2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Gateway Investment Advisers's 13F filing for Q1 2018, filed 12 Apr 2018.